Delivery Order SPE2DB24D1107-SPE2DB25FZEZ7

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,038.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,479.10, is for the delivery of 4,568,033,530 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,776,079 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The $1,126.92 firm fixed-price contract has a completion date of December 23, 2024. It is not designated as a set-aside contract. This award appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $3,492.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $31,743.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,555,721,400 units of the prescription drug dextroamphetamine-amphetamine 20 mg capsules in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of December 15, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award, valued at $2,373.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,076,029 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,810.02 and is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award, valued at $5,457.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order to supply 4,567,771,288 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of April 3, 2025. This award is not associated with a set-aside program and...
This federal contract award, valued at $1,260.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,334,653 units of dextroamphetamine-amphetamine 15 mg capsules, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $2,103.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,982,989 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules in 100-count bottles. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen, designated as SPE2DX, with a total...
  • SPE2DB24D1107
    Indefinite Delivery Contract
  • SPE2DB24D1107-SPE2DB25FZEZ7
    Delivery Order

This federal contract award, valued at $1,439.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,956,585 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules, in 100-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 17, 2025. This award is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract award supports the DLA's mission to supply medical products and pharmaceuticals to the U.S. military and other government agencies.

Generated 7/16/25, 11:58 AM